SAN FRANCISCO and SUZHOU, China, Jan. 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic,...
Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer )
Also on site :
- Major Country Star Forced to Cancel Even More Shows Due to ‘Continued Illness’: ‘My Voice Is Just Not There’
- Walmart Is Selling a 'Fantastic' $400 Charcoal Smoker Grill for Just $110, and Shoppers Say It's 'Perfect for Tailgating and Picnics'
- Orlando Bloom Spotted With Kim Kardashian Amid Katy Perry Split Rumors